Literature DB >> 19303919

Seizure activity involved in the up-regulation of BDNF mRNA expression by activation of central mu opioid receptors.

H N Zhang1, M C Ko.   

Abstract

Chemical-induced seizures up-regulated brain-derived neurotrophic factor (BDNF) mRNA expression. Intracerebroventricular (i.c.v.) administration of endogenous opioids preferentially activating mu opioid receptor (MOR) could also increase BDNF mRNA expression. The aim of this study was to determine to what extent i.c.v. administration of synthetic MOR-selective agonists in rats can modulate both seizure activity and up-regulation of BDNF mRNA expression. Effects and potencies of i.c.v. administration of morphine and [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO), were directly investigated by scoring behavioral seizures and measuring BDNF mRNA expression. In addition, effects of the opioid receptor antagonist naloxone and antiepileptic drugs, diazepam, phenobarbital, and valproate, on i.c.v. MOR agonist-induced behavioral seizures and up-regulation of BDNF mRNA expression were determined. A single i.c.v. administration of morphine (10-100 microg) or DAMGO (0.15-1.5 microg) dose-dependently elicited behavioral seizures and increased BDNF mRNA expression in the widespread brain regions. However, s.c. administration of MOR agonists neither produced behavioral seizures nor increased BDNF mRNA expression. Pretreatment with naloxone 1 mg/kg significantly reduced behavioral seizure scores and the up-regulation of BDNF mRNA expression elicited by i.c.v. morphine or DAMGO. Similarly, diazepam 10 mg/kg and phenobarbital 40 mg/kg significantly blocked i.c.v. MOR agonist-induced actions. Pretreatment with valproate 300 mg/kg only attenuated behavioral seizures, but it did not affect morphine-induced increase of BDNF mRNA expression. This study provides supporting evidence that seizure activity plays an important role in the up-regulation of BDNF mRNA expression elicited by central MOR activation and that decreased inhibitory action of GABAergic system through the modulation on GABA receptor synaptic function by central MOR activation is involved in its regulation of BDNF mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303919      PMCID: PMC2680449          DOI: 10.1016/j.neuroscience.2009.03.020

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  47 in total

1.  Mu-opioid receptors facilitate the propagation of excitatory activity in rat hippocampal area CA1 by disinhibition of all anatomical layers.

Authors:  A Rory McQuiston; Peter Saggau
Journal:  J Neurophysiol       Date:  2003-05-15       Impact factor: 2.714

2.  GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons.

Authors:  Frédéric Marmigère; Florence Rage; Lucia Tapia-Arancibia
Journal:  Neurochem Int       Date:  2003-03       Impact factor: 3.921

3.  Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.

Authors:  Daniel C Broom; Emily M Jutkiewicz; John E Folk; John R Traynor; Kenner C Rice; James H Woods
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

4.  GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats.

Authors:  K Heese; U Otten; P Mathivet; M Raiteri; C Marescaux; R Bernasconi
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

Review 5.  The role of BDNF in epilepsy and other diseases of the mature nervous system.

Authors:  Devin K Binder
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

Review 6.  New insights into BDNF function in depression and anxiety.

Authors:  Keri Martinowich; Husseini Manji; Bai Lu
Journal:  Nat Neurosci       Date:  2007-09       Impact factor: 24.884

7.  Differential expression of brain-derived neurotrophic factor transcripts after pilocarpine-induced seizure-like activity is related to mode of Ca2+ entry.

Authors:  F R Poulsen; J Lauterborn; J Zimmer; C M Gall
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 8.  Pharmacology of valproate.

Authors:  Michael J Owens; Charles B Nemeroff
Journal:  Psychopharmacol Bull       Date:  2003

9.  The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.

Authors:  Mary M Torregrossa; Ceylan Isgor; John E Folk; Kenner C Rice; Stanley J Watson; James H Woods
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

10.  Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain.

Authors:  Brian G Dias; Sunayana B Banerjee; Ronald S Duman; Vidita A Vaidya
Journal:  Neuropharmacology       Date:  2003-09       Impact factor: 5.250

View more
  5 in total

1.  The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats.

Authors:  Pin-Yen Su; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2011-03-18       Impact factor: 4.030

Review 2.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

3.  Changes in mRNA levels for brain-derived neurotrophic factor after wheel running in rats selectively bred for high- and low-aerobic capacity.

Authors:  Jessica L Groves-Chapman; Patrick S Murray; Kristin L Stevens; Derek C Monroe; Lauren G Koch; Steven L Britton; Philip V Holmes; Rod K Dishman
Journal:  Brain Res       Date:  2011-10-06       Impact factor: 3.252

4.  Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats.

Authors:  J R Rozisky; G Laste; I C de Macedo; V S Santos; R Krolow; C Noschang; C Vanzella; K Bertoldi; G A Lovatel; I C C de Souza; I R Siqueira; C Dalmaz; W Caumo; I L S Torres
Journal:  Neurochem Res       Date:  2012-12-09       Impact factor: 3.996

5.  Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.

Authors:  Fani L Neto; Gisela Borges; Sonia Torres-Sanchez; Juan A Mico; Esther Berrocoso
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.